Histopathological Upgrade in Papillary Breast Lesions Diagnosed on Core Needle Biopsy: Predictors and Clinical Implications from a Tertiary Care Cohort Upgrade in Papillary Breast Lesions
Abstract
Background: Papillary breast lesions encompass a heterogeneous spectrum, and core needle biopsy (CNB) may underestimate in situ or invasive malignancy. We evaluated malignant upgrade and preoperative factors associated with upgrade after surgical excision.
Methods: This retrospective cohort study identified 298 patient records with papillary breast lesions. A total of 14 patients were excluded: eight who lacked a preceding CNB, five who did not undergo subsequent surgical excision, and one whose index papillary diagnosis and surgery both occurred before the January 2019–December 2025 study period. This left 284 patients for analysis. Malignant upgrade was defined as ductal carcinoma in situ or invasive malignancy on excision after a benign or atypical papillary lesion on CNB; atypical ductal hyperplasia alone was not considered malignant upgrade. Firth-penalized logistic regression was used to obtain adjusted estimates because a highly predictive atypia variable was present.
Results: Malignant upgrade occurred in 137 of 284 patients (48.2%). Upgrade was observed in 130 of 150 lesions with atypia (86.7%) and 7 of 134 lesions without atypia (5.2%). In adjusted analysis (n = 273 complete cases), atypia on CNB was the strongest independent predictor (adjusted odds ratio [aOR] 71.49, 95% CI 25.96–196.84; P < .001). Increasing age (aOR 1.04 per year, 95% CI 1.01–1.07; P = .02) and manual rather than ultrasound-guided core biopsy (aOR 5.01, 95% CI 1.46–17.20; P = .010) also remained associated with malignant upgrade. Ultrasound lesion size, palpability, peripheral location, and BI-RADS ≥4 were not independently associated with malignant upgrade after adjustment.
Conclusion: Atypia on CNB was associated with a very high probability of malignant upgrade and supports surgical excision. The low upgrade rate among lesions without atypia is hypothesis-generating but cannot establish the safety of surveillance because only surgically excised lesions were analyzed.
References
Rakha EA, Ellis IO. Diagnostic challenges in papillary lesions of the breast. Pathology. 2018;50(1):100-10. doi: 10.1016/j.pathol.2017.10.005
Wen X, Cheng W. Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors. Ann Surg Oncol. 2013;20(1):94-101. doi: 10.1245/s10434-012-2590-1
Renshaw AA, Derhagopian RP, Tizol-Blanco DM, Gould EW. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision. Am J Clin Pathol. 2004;122(2):217-21. doi: 10.1309/K1BNJXETEY3H06UL
Sydnor MK, Wilson JD, Hijaz TA, Massey HD, Shaw de Paredes ES. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy. Radiology. 2007;242(1):58-62. doi: 10.1148/radiol.2421031988
Ahmadiyeh N, Stoleru MA, Raza S, Lester SC, Golshan M. Management of intraductal papillomas of the breast: an analysis of 129 cases and their outcome. Ann Surg Oncol. 2009;16(8):2264-9. doi: 10.1245/s10434-009-0534-1
Salisbury T, Gurung A, Koonmee S, Ali L, Ondic O, Bhan R, et al. Upgrade rate and predictive factors associated with breast papillary lesions on core biopsy: a Canadian experience. Int J Surg Pathol. 2023;31(7):1206-16. doi: 10.1177/10668969221137515
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296. doi: 10.1371/journal.pmed.0040296
Park J, Lee NR, Oh HK, Park SH, Kim JK, Jeong YJ. Factors associated with upgrade, malignant upgrade, and subsequent breast cancer occurrence of papillary breast lesions diagnosed on core needle biopsy. Asia Pac J Clin Oncol. 2023;19(2):e96-e105. doi: 10.1111/ajco.13798
WHO Classification of Tumors Editorial Board. Breast tumors. Lyon, France: International Agency for Research on Cancer; 2019;2.
Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med. 2002;21:2409-19. doi: 10.1002/sim.1047
Jakate K, De Brot M, Goldberg F, Muradali D, O’Malley FP, Mulligan AM. Papillary lesions of the breast: impact of breast pathology subspecialization on core biopsy and excision diagnoses. Am J Surg Pathol. 2012;36(4):544-51. doi: 10.1097/PAS.0b013e318243fa00
Agoumi M, Giambattista J, Hayes MM. Practical considerations in breast papillary lesions: a review of the literature. Arch Pathol Lab Med. 2016;140(8):770-80. doi: 10.5858/arpa.2015-0525-RA
Shiino S, Tsuda H, Yoshida M, Jimbo K, Asaga S, Hojo T, et al. Intraductal papillomas on core biopsy can be upgraded to malignancy on subsequent excisional biopsy regardless of the presence of atypical features. Pathol Int. 2015;65(6):293-300. doi: 10.1111/pin.12285
Authors
Copyright (c) 2026 Maleeha Khan Lodhi, Rufina Soomro
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright©. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International License, which permits copy and redistribution of the material in any medium or format or adapt, remix, transform, and build upon the material for any purpose, except for commercial purposes.